NVO ▼ -1.4% - Novo Nordisk A/S $NVO d/g Underweight @ MS Novo Nordisk shares declined 1.4% following a downgrade to Underweight from Morgan Stanley, reflecting the analyst firm's more cautious stance on the company's near-term prospects. 11-SEP-2026 05:14 AM ET